Clinical Trial Update: A Study to Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese Patients [Phase 3]

View source ↗

Summary

Phase 3 study comparing ziprasidone to risperidone for schizophrenia in Chinese patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• RISPERIDONE (RISPERIDONE)
• Ziprasidone (ziprasidone)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED